from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1758/cut1

LFCtreatmentdescriptionclass of inhibitor

0.044

Amikacinug/mL Amikacintranslation

-0.820

Cap5-10ug/mL Capreomycintranslation

-0.091

Rox10-50 ug/mL Roxithromycintranslation

-0.926

SM2-5 ug/mL Streptomycintranslation

0.000

Tet5-10 ug/mL Tetracyclinetranslation

0.956

Rif0.2-5ug/mL Rifampicintranscription

0.151

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.660

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.242

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.146

CPZ10-50 ug/mL Chlorpromazinerespiration

0.615

Clofazimine10-13 ug/mL Clofaziminerespiration

0.066

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.088

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.082

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.168

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.274

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.254

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-1.369

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.492

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.360

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.991

KCN5-20 ug/mL Potassium cyaniderespiration

-0.519

NaN30.2-2 mM Sodium aziderespiration

-1.317

Nigericin50 uM Nigericinrespiration

0.450

TRC10-150 ug/mL Triclosanrespiration

0.277

TRZ10-25 ug/mL Thioridazinerespiration

-1.490

Valinomycin0.5-10 uM Valinomycinrespiration

0.000

ZnSO42 mM ZnSO4respiration

-1.270

menadione6-10 ug/mL Menadionerespiration

0.420

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.440

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.061

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-1.280

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-2.124

NRP_1Non-replicating persistence stage 1dosRassociated

-0.292

Amp0.2mg/mL AmpicillincellWall

-0.589

Cephalexin20-100 ug/mL CephalexincellWall

0.939

Cerulenin0.32-5 ug/mL CerulenincellWall

0.242

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.031

EMB10-20 ug/mL EthambutolcellWall

0.221

Eta12-40 ug/mL EthionamidecellWall

0.073

INH0.2-0.4 ug/mL IsoniazidcellWall

0.424

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.763

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.775

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.309

BZA0.12 mg/mL BenzamidearomaticAmides

0.451

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.037

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.697

H2O24 mM hydrogen peroxideDNAdamaging

-0.216

Levo10 ug/mL LevofloxacinDNAdamaging

0.405

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.686

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.658

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.023

UVUV-irradiationDNAdamaging

-0.999

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.564

Antimycin12.5-50 ug/mL Antimycin A?

-1.213

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.791

PA_110-50 ug/mL Antitubercular compound PA-1?

0.567

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.604

PA8240.2-2 ug/mL PA-824?

0.679

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.995

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-1.478

Verapamil50 uM Verapamil?

-1.057

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.972

methoxatin10-20 ug/mL Methoxatin?